Latest Capital Structure News

Bio-Gene Technology narrowed its loss to $2.33 million in FY26 while progressing key toxicity studies for Flavocide and securing a commercial foothold for Qcide in Japan. The company bolstered its balance sheet with a $3.275 million capital raise to fund ongoing development and production scale-up.

Foresta Group Holdings reports a doubling of its net loss to $6.8 million for FY2026 amid steady progress on its Kawerau biomass facility, highlighted by a long-term lease and key technical studies.

Beonic Limited has completed a three-year turnaround, reporting a profitable FY26 with EBITDA of A$4.0m and a 17.2% margin. The company’s unified spatial analytics platform and new AI product underpin FY27 growth guidance targeting ~A$20m ARR and a 19% EBITDA margin.

Saturn Metals has significantly oversubscribed its Share Purchase Plan, raising $21.28 million against a $5 million target. Combined with a recent $100 million placement, the company now has $121.28 million to accelerate development of its Apollo Hill Gold Project in Western Australia.

Farm Pride Foods Ltd reported a 16% revenue increase to $118.3 million and a 53% jump in net profit to $10.2 million for FY26, underpinned by operational improvements and strategic capital investments.

CleanSpace Holdings is set to repurchase up to 10% of its shares over the next year, signalling confidence in its growth prospects and capital position.

MA Credit Income Trust (ASX:MA1) posted a robust 8.56% net return for FY2026, surpassing its target, alongside a fully subscribed $190.5 million capital raise and strategic buy-back initiatives.

Careteq Limited (ASX: CTQ) reported a $398K net loss for FY26 amid a strategic reset that included selling its Embedded Health Solutions business and repaying all debt. The company now pivots fully to growing its HMR Referrals platform with $3.19 million cash on hand.

NewPeak Metals has finalised its second tranche placement, issuing over 231 million shares and raising $2.86 million before costs, including repayment of director entitlements.

CTI Logistics (ASX:CLX) posted a 69% jump in net profit to $24 million for FY26, driven by robust transport volumes, logistics growth and a $74 million uplift in property valuations. The company also declared a 14 cents per share fully franked dividend.

An application to the Takeovers Panel challenges the integrity of A2MP's takeover bid for Canyon Resources, citing misleading statements and undisclosed shareholder dealings amid project financing uncertainty.

Genetic Signatures (ASX: GSS) and Microba Life Sciences (ASX: MAP) are in early talks about merging to form a larger infectious disease diagnostics entity, combining rapid pathogen detection with microbiome profiling. The proposed group would have FY2026 pro forma revenue of around A$29 million and a stronger financial footing.